S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NASDAQ:FONR

FONAR - FONR Stock Forecast, Price & News

$17.63
-0.07 (-0.40%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.63
$17.98
50-Day Range
$14.95
$18.82
52-Week Range
$13.28
$19.32
Volume
4,307 shs
Average Volume
16,355 shs
Market Capitalization
$115.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FONR stock logo

About FONAR (NASDAQ:FONR) Stock

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

FONR Stock News Headlines

FONAR Reports First Quarter 2023 Earnings
Fonar Corporation Common Stock (FONR)
FONAR Corporation (FONR)
See More Headlines
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

FONR Company Calendar

Last Earnings
5/11/2020
Today
12/09/2022
Next Earnings (Estimated)
2/21/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FONR
Employees
495
Year Founded
N/A

Profitability

Net Income
$12.44 million
Pretax Margin
20.84%

Debt

Sales & Book Value

Annual Sales
$97.59 million
Cash Flow
$3.89 per share
Book Value
$22.31 per share

Miscellaneous

Free Float
5,992,000
Market Cap
$115.55 million
Optionable
Not Optionable
Beta
0.81

Key Executives

  • Mr. Timothy R. Damadian (Age 58)
    Chairman, Pres, CEO & Treasurer
    Comp: $305.8k
  • Mr. Luciano B. Bonanni (Age 67)
    COO, Exec. VP & Acting Principal Financial Officer
    Comp: $454.37k
  • Ms. Claudette J. V. Chan (Age 84)
    Sec. & Director
    Comp: $58.88k
  • Mr. Daniel Culver
    Director of Communications













FONR Stock - Frequently Asked Questions

How have FONR shares performed in 2022?

FONAR's stock was trading at $14.98 at the start of the year. Since then, FONR stock has increased by 17.7% and is now trading at $17.63.
View the best growth stocks for 2022 here
.

When is FONAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our FONR earnings forecast
.

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) released its quarterly earnings results on Monday, May, 11th. The medical equipment provider reported $0.18 earnings per share (EPS) for the quarter. The medical equipment provider earned $21.69 million during the quarter. FONAR had a trailing twelve-month return on equity of 8.28% and a net margin of 10.92%.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL).

What is FONAR's stock symbol?

FONAR trades on the NASDAQ under the ticker symbol "FONR."

Who are FONAR's major shareholders?

FONAR's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (10.75%), Dimensional Fund Advisors LP (5.93%), Renaissance Technologies LLC (5.27%), LSV Asset Management (2.31%), Money Concepts Capital Corp (2.21%) and BlackRock Inc. (1.49%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian.
View institutional ownership trends
.

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is FONAR's stock price today?

One share of FONR stock can currently be purchased for approximately $17.63.

How much money does FONAR make?

FONAR (NASDAQ:FONR) has a market capitalization of $115.55 million and generates $97.59 million in revenue each year.

How many employees does FONAR have?

The company employs 495 workers across the globe.

How can I contact FONAR?

FONAR's mailing address is 110 Marcus Drive, Melville NY, 11747. The official website for the company is www.fonar.com. The medical equipment provider can be reached via phone at (631) 694-2929, via email at investor@fonar.com, or via fax at 631-753-5150.

This page (NASDAQ:FONR) was last updated on 12/9/2022 by MarketBeat.com Staff